This report was recently updated on July 20 2024 with the latest and most recent
market numbers
Global Clinical Oncology Next Generation Sequencing Market Size, Trends & Analysis - Forecasts to 2028 By Application Type (Screening, Companion Diagnostics, and Other Diagnostics), By End User (Hospitals, Clinics, and Laboratories), By Technology Type (Whole Genome Sequencing, Whole Exome Sequencing, and Targeted Sequencing & Resequencing), By Workflow Type (NGS Pre-Sequencing, NGS Sequencing, and NGS Data Analysis), and By Region (North America, Asia Pacific, Central & South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis
The global clinical oncology next generation sequencing market is expected to grow at a CAGR of 16.4% from 2023 to 2028.
Cancer diagnostics is experiencing rapid evolution with the emergence of the clinical oncology next-generation sequencing (NGS) market. NGS enables comprehensive analysis of tumor genomes, helping clinicians to identify genetic alterations that drive cancer development and progression. This technology provides insights into individualized treatment strategies, such as targeted therapies and immunotherapies, leading to improved patient outcomes. The market is witnessing significant growth due to rising cancer incidence, advancements in sequencing technologies, and decreasing costs associated with NGS. Clinical oncology NGS offers advantages like high-throughput sequencing, simultaneous detection of multiple gene alterations, and the potential for non-invasive liquid biopsies. However, challenges remain, including data interpretation and standardization, reimbursement issues, and regulatory considerations. Overall, the clinical oncology NGS market holds immense potential to revolutionize cancer care by enabling precise and personalized treatments.
Various factors drive the clinical oncology next-generation sequencing (NGS) market. Technological advancements, increasing competition, rising healthcare spending, and the growing prevalence of cancer are key drivers. The market was influenced by the COVID-19 pandemic, which led to the implementation of regulatory guidelines and broader inclusion of NGS tests in healthcare coverage. The clinical applications of NGS in precision oncology and the ability to determine viral genetic sequences further contribute to market growth. Additionally, the rising global cancer incidence and the use of NGS in liquid biopsy and personalized medicine drive the market growth. Overall, the adoption of NGS technology, its cost-effectiveness, speed, and application in cancer research propel the clinical oncology NGS market growth.
The companies operating in the clinical oncology next-generation sequencing (NGS) market have promising prospects and ample opportunities for growth in the future. The expanding application of NGS in precision oncology presents avenues for companies to develop novel platforms and solutions for genomic insights. The rising demand for NGS in liquid biopsy offers prospects for revenue generation, enabling effective profiling and real-time monitoring of cancers. Furthermore, the increasing adoption of companion diagnostics and personalized medicine creates opportunities for companies to develop and offer NGS-based diagnostic tests and targeted therapies. Technological advancements in NGS and bioinformatics tools open doors for companies to revolutionize cancer research, diagnosis, and therapy. With the growing global prevalence of cancer, companies have the opportunity to meet the demand for accurate and efficient NGS solutions in the oncology field, driving growth and innovation in the market.
Based on the technology type, the market is segmented into whole genome sequencing, whole exome sequencing, and targeted sequencing & resequencing. The targeted sequencing & resequencing segment is anticipated to be the largest segment during the forecast period. This is due to its advantages, including time and cost savings and efficient detection of malignant tumours. Clinical studies have demonstrated the high clinical utility of targeted panels, making them a preferred choice in around 64% of cancer cases.
Based on the application type, the market is segmented into screening, companion diagnostics, and other diagnostics. The screening segment is projected to be the largest segment during the forecast period. This is due to its widespread utilization in cancer screening programs globally. NGS-based testing is highly efficient in identifying genetic alterations for targeted clinical benefits, allowing simultaneous assessment of multiple gene alterations by clinicians.
Based on the workflow type, the market is segmented into NGS pre-sequencing, NGS sequencing, and NGS data analysis. The NGS sequencing segment is anticipated to be the dominant segment during the forecast period, attributed to its critical role in the complete sequencing workflow. With the use of cutting-edge platforms, NGS sequencing has become essential for comprehensive analysis. The segment's growth is further fuelled by the increasing number of cancer sequencing projects, which analyse numerous tumour samples across various cancer types.
Based on the end user, the market is segmented into hospitals, clinics, and laboratories. The laboratories segment is expected to be the largest segment during the forecast period. This is because of pre-existing workflows, detailed guidelines, and regulatory control. Developed laboratories have established standardized procedures, and FDA-approved tests come with specified standards and performance characteristics. Governing bodies like the CMS (Centres for Medicare and Medicaid Services) and state-level authorities ensure compliance, while organizations like ACMG, AMP, and CAP provide best practice guidelines for clinical laboratories.
North America is analyzed to be the largest region in the global clinical oncology next generation sequencing market in the forecast period. This can be attributed to several factors. Regulatory bodies in the United States are implementing measures to enhance cancer screening and diagnosis, boosting the demand for NGS technologies. Additionally, the region witnesses substantial research and development investments, driving innovation and technological advancements in NGS. The combination of supportive regulatory frameworks, increased R&D investments, and the presence of leading players has contributed to North America's leadership in the clinical oncology NGS market.
Asia Pacific is also analyzed to be the fastest-growing region across the global clinical oncology next generation sequencing market. This can be attributed to several factors, including decreased sequencing costs, favourable government policies, rising investments in research and development (R&D), and competitive pricing strategies by key market players. China, in particular, has witnessed a significant decline in sequencing costs, making NGS services and products more affordable than other countries. The market growth in the APAC region is further fuelled by supportive government policies and substantial investments by key players, creating a conducive environment for expanding clinical oncology NGS technologies in the region.
The key players operating in the market are Illumina Inc., Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd., Agilent Technologies, Myriad Genetics, Perkin Elmer, Caris Life Sciences, Partek, Inc., Eurofins Scientific, and Qiagen N.V. among others.
Please note: This is not an exhaustive list of companies profiled in the report.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2 TECHNOLOGICAL TRENDS
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
3 GLOBAL MARKET OUTLOOK
3.1 Market Pyramid Analysis
3.1.1 Introduction
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2 Demand Side Analysis
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3 Supply Side Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
3.3.2.1 Political Landscape
3.3.2.2 Economic Landscape
3.3.2.3 Social Landscape
3.3.2.4 Technology Landscape
3.3.3 Value Chain Analysis
3.3.4 Trend Analysis
3.3.5 Gap Analysis
3.3.6 Cost Analysis
4 GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY TYPE
4.1 Introduction
4.2 Clinical Oncology Next Generation Sequencing Market: Technology Type Scope Key Takeaways
4.3 Revenue Growth Analysis, 2022 & 2028
4.4 Whole Genome Sequencing
4.4.1 Whole Genome Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
4.5 Whole Exome Sequencing
4.5.1 Whole Exome Sequencing Market Estimates And Forecast, 2020-2028 (USD Billion)
4.6 Targeted Sequencing & Resequencing
4.6.1 Targeted Sequencing & Resequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
5 GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY END USER
5.1 Introduction
5.2 Clinical Oncology Next Generation Sequencing Market: End User Scope Key Takeaways
5.3 Revenue Growth Analysis, 2022 & 2028
5.4 Hospitals
5.4.1 Hospitals Market Estimates and Forecast, 2020-2028 (USD Billion)
5.5 Clinics
5.5.1 Clinics Market Estimates and Forecast, 2020-2028 (USD Billion)
5.6 Laboratories
5.6.1 Laboratories Market Estimates and Forecast, 2020-2028 (USD Billion)
6 GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY APPLICATION TYPE
6.1 Introduction
6.2 Clinical Oncology Next Generation Sequencing Market: Application Type Scope Key Takeaways
6.3 Revenue Growth Analysis, 2022 & 2028
6.4 Screening
6.4.1 Screening Market Estimates and Forecast, 2020-2028 (USD Billion)
6.5 Companion Diagnostics
6.5.1 Companion Diagnostics Market Estimates and Forecast, 2020-2028 (USD Billion)
6.6 Other Diagnostics
6.6.1 Other Diagnostics Market Estimates and Forecast, 2020-2028 (USD Billion)
7 GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY WORKFLOW TYPE
7.1 Introduction
7.2 Clinical Oncology Next Generation Sequencing Market: Workflow Type Scope Key Takeaways
7.3 Revenue Growth Analysis, 2022 & 2028
7.4 NGS Pre-Sequencing
7.4.1 NGS Pre-Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
7.5 NGS Sequencing
7.5.1 NGS Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
7.6 NGS Data Analysis
7.6.1 NGS Data Analysis Market Estimates and Forecast, 2020-2028 (USD Billion)
8 GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY REGION
8.1 Introduction
8.2 North America Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.2.1 By Technology Type
8.2.2 By End User
8.2.3 By Application Type
8.2.4 By Workflow Type
8.2.5 By Country
8.2.5.1 U.S. Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.2.5.1.1 By Technology Type
8.2.5.1.2 By End User
8.2.5.1.3 By Application Type
8.2.5.1.4 By Workflow Type
8.2.5.2 Canada Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.2.5.2.1 By Technology Type
8.2.5.2.2 By End User
8.2.5.2.3 By Application Type
8.2.5.2.4 By Workflow Type
8.2.5.3 Mexico Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.2.5.3.1 By Technology Type
8.2.5.3.2 By End User
8.2.5.3.3 By Application Type
8.2.5.3.4 By Workflow Type
8.3 Europe Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.3.1 By Technology Type
8.3.2 By End User
8.3.3 By Application Type
8.3.4 By Workflow Type
8.3.5 By Country
8.3.5.1 Germany Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.3.5.1.1 By Technology Type
8.3.5.1.2 By End User
8.3.5.1.3 By Application Type
8.3.5.1.4 By Workflow Type
8.3.5.2 U.K. Presered Flowers Market Estimates and Forecast, 2020-2028 (USD Billion)
8.3.5.2.1 By Technology Type
8.3.5.2.2 By End User
8.3.5.2.3 By Application Type
8.3.5.2.4 By Workflow Type
8.3.5.3 France Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.3.5.3.1 By Technology Type
8.3.5.3.2 By End User
8.3.5.3.3 By Application Type
8.3.5.3.4 By Workflow Type
8.3.5.4 Italy Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.3.5.4.1 By Technology Type
8.3.5.4.2 By End User
8.3.5.4.3 By Application Type
8.3.5.4.4 By Workflow Type
8.3.5.5 Spain Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.3.5.5.1 By Technology Type
8.3.5.5.2 By End User
8.3.5.5.3 By Application Type
8.3.5.5.4 By Workflow Type
8.3.5.6 Netherlands Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.3.5.6.1 By Technology Type
8.3.5.6.2 By End User
8.3.5.6.3 By Application Type
8.3.5.6.4 By Workflow Type
8.3.5.7 Rest of Europe Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.3.5.7.1 By Technology Type
8.3.5.7.2 By End User
8.3.5.7.3 By Application Type
8.3.5.7.4 By Workflow Type
8.4 Asia Pacific Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.1 By Technology Type
8.4.2 By End User
8.4.3 By Application Type
8.4.4 By Workflow Type
8.4.5 By Country
8.4.5.1 China Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.1.1 By Technology Type
8.4.5.1.2 By End User
8.4.5.1.3 By Application Type
8.4.5.1.4 By Workflow Type
8.4.5.2 Japan Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.2.1 By Technology Type
8.4.5.2.2 By End User
8.4.5.2.3 By Application Type
8.4.5.2.4 By Workflow Type
8.4.5.3 India Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.3.1 By Technology Type
8.4.5.3.2 By End User
8.4.5.3.3 By Application Type
8.4.5.3.4 By Workflow Type
8.4.5.4 South Korea Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.4.1 By Technology Type
8.4.5.4.2 By End User
8.4.5.4.3 By Application Type
8.4.5.4.4 By Workflow Type
8.4.5.5 Singapore Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.5.1 By Technology Type
8.4.5.5.2 By End User
8.4.5.5.3 By Application Type
8.4.5.5.4 By Workflow Type
8.4.5.6 Malaysia Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.6.1 By Technology Type
8.4.5.6.2 By End User
8.4.5.6.3 By Application Type
8.4.5.6.4 By Workflow Type
8.4.5.7 Thailand Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.7.1 By Technology Type
8.4.5.7.2 By End User
8.4.5.7.3 By Application Type
8.4.5.7.4 By Workflow Type
8.4.5.8 Indonesia Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.8.1 By Technology Type
8.4.5.8.2 By End User
8.4.5.8.3 By Application Type
8.4.5.8.4 By Workflow Type
8.4.5.9 Vietnam Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.9.1 By Technology Type
8.4.5.9.2 By End User
8.4.5.9.3 By Application Type
8.4.5.9.4 By Workflow Type
8.4.5.10 Taiwan Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.10.1 By Technology Type
8.4.5.10.2 By End User
8.4.5.10.3 By Application Type
8.4.5.10.4 By Workflow Type
8.4.5.11 Rest of Asia Pacific Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.4.5.11.1 By Technology Type
8.4.5.11.2 By End User
8.4.5.11.3 By Application Type
8.4.5.11.4 By Workflow Type
8.5 Middle East and Africa Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.5.1 By Technology Type
8.5.2 By End User
8.5.3 By Application Type
8.5.4 By Workflow Type
8.5.5 By Country
8.5.5.1 Saudi Arabia Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.5.5.1.1 By Technology Type
8.5.5.1.2 By End User
8.5.5.1.3 By Application Type
8.5.5.1.4 By Workflow Type
8.5.5.2 U.A.E. Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.5.5.2.1 By Technology Type
8.5.5.2.2 By End User
8.5.5.2.3 By Application Type
8.5.5.2.4 By Workflow Type
8.5.5.3 Israel Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.5.4.3.1 By Technology Type
8.5.4.3.2 By End User
8.5.4.3.3 By Application Type
8.5.5.3.4 By Workflow Type
8.5.5.4 South Africa Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.5.5.4.1 By Technology Type
8.5.5.4.2 By End User
8.5.5.4.3 By Application Type
8.5.5.4.4 By Workflow Type
8.5.5.5 Rest of Middle East and Africa Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.5.5.5.1 By Technology Type
8.5.5.5.2 By End User
8.5.5.5.2 By Application Type
8.5.5.5.4 By Workflow Type
8.6 Central & South America Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.6.1 By Technology Type
8.6.2 By End User
8.6.3 By Application Type
8.6.4 By Workflow Type
8.6.5 By Country
8.6.5.1 Brazil Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.6.5.1.1 By Technology Type
8.6.5.1.2 By End User
8.6.5.1.3 By Application Type
8.6.5.1.4 By Workflow Type
8.6.5.2 Argentina Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.6.5.2.1 By Technology Type
8.6.5.2.2 By End User
8.6.5.2.3 By Application Type
8.6.5.2.4 By Workflow Type
8.6.5.3 Chile Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.6.5.3.1 By Technology Type
8.6.5.3.2 By End User
8.6.5.3.3 By Application Type
8.6.5.5.4 By Workflow Type
8.6.5.4 Rest of Central & South America Clinical Oncology Next Generation Sequencing Market Estimates and Forecast, 2020-2028 (USD Billion)
8.6.5.4.1 By Technology Type
8.6.5.4.2 By End User
8.6.5.4.3 By Application Type
8.6.5.4.4 By Workflow Type
9 COMPETITIVE LANDCAPE
9.1 Company Market Share Analysis
9.2 Four Quadrant Positioning Matrix
9.2.1 Market Leaders
9.2.2 Market Visionaries
9.2.3 Market Challengers
9.2.4 Niche Market Players
9.3 Vendor Landscape
9.3.1 North America
9.3.2 Europe
9.3.3 Asia Pacific
9.3.4 Rest of the World
9.4 Company Profiles
9.4.1 Illumina Inc.
9.4.1.1 Business Description & Financial Analysis
9.4.1.2 SWOT Analysis
9.4.1.3 Products & Services Offered
9.4.1.4 Strategic Alliances between Business Partners
9.4.2 Thermo Fisher Scientific
9.4.2.1 Business Description & Financial Analysis
9.4.2.2 SWOT Analysis
9.4.2.3 Products & Services Offered
9.4.2.4 Strategic Alliances between Business Partners
9.4.3 F. Hoffmann-La Roche Ltd.
9.4.3.1 Business Description & Financial Analysis
9.4.3.2 SWOT Analysis
9.4.3.3 Products & Services Offered
9.4.3.4 Strategic Alliances between Business Partners
9.4.4 Agilent Technologies
9.4.4.1 Business Description & Financial Analysis
9.4.4.2 SWOT Analysis
9.4.4.3 Products & Services Offered
9.4.4.4 Strategic Alliances between Business Partners
9.4.5 Myriad Genetics
9.4.5.1 Business Description & Financial Analysis
9.4.5.2 SWOT Analysis
9.4.5.3 Products & Services Offered
9.4.5.4 Strategic Alliances between Business Partners
9.4.6 Perkin Elmer
9.4.6.1 Business Description & Financial Analysis
9.4.6.2 SWOT Analysis
9.4.6.3 Products & Services Offered
9.4.6.4 Strategic Alliances between Business Partners
9.4.7 Caris Life Sciences
9.4.7.1 Business Description & Financial Analysis
9.4.7.2 SWOT Analysis
9.4.7.3 Products & Services Offered
9.4.8.4 Strategic Alliances between Business Partners
9.4.8 Eurofins Scientific
9.4.8.1 Business Description & Financial Analysis
9.4.8.2 SWOT Analysis
9.4.8.3 Products & Services Offered
9.4.8.4 Strategic Alliances between Business Partners
9.4.9 Qiagen
9.4.9.1 Business Description & Financial Analysis
9.4.9.2 SWOT Analysis
9.4.9.3 Products & Services Offered
9.4.9.4 Strategic Alliances between Business Partners
9.4.10 Other Companies
9.4.10.1 Business Description & Financial Analysis
9.4.10.2 SWOT Analysis
9.4.10.3 Products & Services Offered
9.4.10.4 Strategic Alliances between Business Partners
10 RESEARCH METHODOLOGY
10.1 Market Introduction
10.1.1 Market Definition
10.1.2 Market Scope & Segmentation
10.2 Information Procurement
10.2.1 Secondary Research
10.2.1.1 Purchased Databases
10.2.1.2 GMEs Internal Data Repository
10.2.1.3 Secondary Resources & Third Party Perspectives
10.2.1.4 Company Information Sources
10.2.2 Primary Research
10.2.2.1 Various Types of Respondents for Primary Interviews
10.2.2.2 Number of Interviews Conducted throughout the Research Process
10.2.2.3 Primary Stakeholders
10.2.2.4 Discussion Guide for Primary Participants
10.2.3 Expert Panels
10.2.3.1 Expert Panels Across 30+ Industry
10.2.4 Paid Local Experts
10.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
10.3 Market Estimation
10.3.1 Top-Down Approach
10.3.1.1 Macro-Economic Indicators Considered
10.3.1.2 Micro-Economic Indicators Considered
10.3.2 Bottom Up Approach
10.3.2.1 Company Share Analysis Approach
10.3.2.2 Estimation of Potential Product Sales
10.4 Data Triangulation
10.4.1 Data Collection
10.4.2 Time Series, Cross Sectional & Panel Data Analysis
10.4.3 Cluster Analysis
10.5 Analysis and Output
10.5.1 Inhouse AI Based Real Time Analytics Tool
10.5.2 Output From Desk & Primary Research
10.6 Research Assumptions & Limitations
10.7.1 Research Assumptions
10.7.2 Research Limitations
LIST OF TABLES
1 Global Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)
2 Whole Genome Sequencing Market, By Region, 2020-2028 (USD Billion)
3 WHOLE EXOME SEQUENCING Market, By Region, 2020-2028 (USD Billion)
4 Targeted Sequencing & Resequencing Market, By Region, 2020-2028 (USD Billion)
5 Global Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)
6 Hospitals Market, By Region, 2020-2028 (USD Billion)
7 CLINICS Market, By Region, 2020-2028 (USD Billion)
8 Laboratories Market, By Region, 2020-2028 (USD Billion)
9 Global Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)
10 Screening Market, By Region, 2020-2028 (USD Billion)
11 Companion Diagnostics Market, By Region, 2020-2028 (USD Billion)
12 Biometrics Market, By Region, 2020-2028 (USD Billion)
13 Other Diagnostics Market, By Region, 2020-2028 (USD Billion)
14 Global Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)
15 NGS Pre-Sequencing Market, By Region, 2020-2028 (USD Billion)
16 NGS Sequencing Market, By Region, 2020-2028 (USD Billion)
17 NGS Data Analysis Market, By Region, 2020-2028 (USD Billion)
18 Regional Analysis, 2020-2028 (USD Billion)
19 North America Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)
20 North America Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)
21 North America Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)
22 North America Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)
23 North America Clinical Oncology Next Generation Sequencing Market, By Country, 2020-2028 (USD Billion)
24 U.S Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)
25 U.S Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)
26 U.S Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)
27 U.S Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)
28 Canada Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)
29 Canada Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)
30 Canada Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)
31 CANADA Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)
32 Mexico Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)
33 Mexico Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)
34 Mexico Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)
35 mexico Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)
36 Europe Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)
37 Europe Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)
38 Europe Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)
39 europe Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)
40 Germany Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)
41 Germany Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)
42 Germany Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)
43 germany Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)
44 UK Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)
45 UK Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)
46 UK Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)
47 U.k Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)
48 France Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)
49 France Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)
50 France Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)
51 france Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)
52 Italy Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)
53 Italy Clinical Oncology Next Generation Sequencing Market, By T End User Type, 2020-2028 (USD Billion)
54 Italy Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)
55 italy Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)
56 Spain Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)
57 Spain Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)
58 Spain Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)
59 spain Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)
60 Rest Of Europe Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)
61 Rest Of Europe Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)
62 Rest of Europe Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)
63 REST OF EUROPE Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)
64 Asia Pacific Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)
65 Asia Pacific Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)
66 Asia Pacific Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)
67 asia Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)
68 Asia Pacific Clinical Oncology Next Generation Sequencing Market, By Country, 2020-2028 (USD Billion)
69 China Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)
70 China Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)
71 China Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)
72 china Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)
73 India Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)
74 India Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)
75 India Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)
76 india Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)
77 Japan Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)
78 Japan Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)
79 Japan Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)
80 japan Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)
81 South Korea Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)
82 South Korea Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)
83 South Korea Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)
84 south korea Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)
85 Middle East and Africa Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)
86 Middle East and Africa Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)
87 Middle East and Africa Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)
88 MIDDLE EAST AND AFRICA Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)
89 Middle East and Africa Clinical Oncology Next Generation Sequencing Market, By Country, 2020-2028 (USD Billion)
90 Saudi Arabia Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)
91 Saudi Arabia Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)
92 Saudi Arabia Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)
93 saudi arabia Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)
94 UAE Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)
95 UAE Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)
96 UAE Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)
97 uae Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)
98 Central & South America Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)
99 Central & South America Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)
100 Central & South America Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)
101 CENTRAL & SOUTH AMERICA Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)
102 Central & South America Clinical Oncology Next Generation Sequencing Market, By Country, 2020-2028 (USD Billion)
103 Brazil Clinical Oncology Next Generation Sequencing Market, By Technology Type, 2020-2028 (USD Billion)
104 Brazil Clinical Oncology Next Generation Sequencing Market, By End User, 2020-2028 (USD Billion)
105 Brazil Clinical Oncology Next Generation Sequencing Market, By Application Type, 2020-2028 (USD Billion)
106 brazil Clinical Oncology Next Generation Sequencing Market, By Workflow Type, 2020-2028 (USD Billion)
107 Illumina Inc.: Products & Services Offering
108 Thermo Fisher Scientific: Products & Services Offering
109 F. Hoffmann-La Roche Ltd.: Products & Services Offering
110 Agilent Technologies: Products & Services Offering
111 Myriad Genetics: Products & Services Offering
112 PERKIN ELMER: Products & Services Offering
113 Caris Life Sciences: Products & Services Offering
114 Eurofins Scientific: Products & Services Offering
115 Qiagen, Inc: Products & Services Offering
116 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global Clinical Oncology Next Generation Sequencing Market Overview
2 Global Clinical Oncology Next Generation Sequencing Market Value From 2020-2028 (USD Billion)
3 Global Clinical Oncology Next Generation Sequencing Market Share, By Technology Type (2022)
4 Global Clinical Oncology Next Generation Sequencing Market Share, By End User (2022)
5 Global Clinical Oncology Next Generation Sequencing Market Share, By Application Type (2022)
6 Global Clinical Oncology Next Generation Sequencing Market Share, By Workflow Type (2022)
7 Global Clinical Oncology Next Generation Sequencing Market, By Region (Asia Pacific Market)
8 Technological Trends In Global Clinical Oncology Next Generation Sequencing Market
9 Four Quadrant Competitor Positioning Matrix
10 Impact Of Macro & Micro Indicators On The Market
11 Impact Of Key Drivers On The Global Clinical Oncology Next Generation Sequencing Market
12 Impact Of Challenges On The Global Clinical Oncology Next Generation Sequencing Market
13 Porter’s Five Forces Analysis
14 Global Clinical Oncology Next Generation Sequencing Market: By Technology Type Scope Key Takeaways
15 Global Clinical Oncology Next Generation Sequencing Market, By Technology Type Segment: Revenue Growth Analysis
16 Whole Genome Sequencing Market, By Region, 2020-2028 (USD Billion)
17 Whole Exome Sequencing Market, By Region, 2020-2028 (USD Billion)
18 Targeted Sequencing & Resequencing Market, By Region, 2020-2028 (USD Billion)
19 Global Clinical Oncology Next Generation Sequencing Market: By End User Scope Key Takeaways
20 Global Clinical Oncology Next Generation Sequencing Market, By End User Segment: Revenue Growth Analysis
21 Hospitals Market, By Region, 2020-2028 (USD Billion)
22 Clinics Market, By Region, 2020-2028 (USD Billion)
23 Laboratories Market, By Region, 2020-2028 (USD Billion)
24 Global Clinical Oncology Next Generation Sequencing Market: By Application Type Scope Key Takeaways
25 Global Clinical Oncology Next Generation Sequencing Market, By Application Type Segment: Revenue Growth Analysis
26 Screening Market, By Region, 2020-2028 (USD Billion)
27 Companion Diagnostics Market, By Region, 2020-2028 (USD Billion)
28 Biometrics Market, By Region, 2020-2028 (USD Billion)
29 Other Diagnostics Market, By Region, 2020-2028 (USD Billion)
30 Global Clinical Oncology Next Generation Sequencing Market: By Workflow Type Scope Key Takeaways
31 Global Clinical Oncology Next Generation Sequencing Market, By Workflow Type Segment: Revenue Growth Analysis
32 NGS Pre-Sequencing Market, By Region, 2020-2028 (USD Billion)
33 NGS Sequencing Market, By Region, 2020-2028 (USD Billion)
34 NGS Data Analysis Market, By Region, 2020-2028 (USD Billion)
35 Regional Segment: Revenue Growth Analysis
36 Global Clinical Oncology Next Generation Sequencing Market: Regional Analysis
37 North America Clinical Oncology Next Generation Sequencing Market Overview
38 North America Clinical Oncology Next Generation Sequencing Market, By Technology Type
39 North America Clinical Oncology Next Generation Sequencing Market, By End User
40 North America Clinical Oncology Next Generation Sequencing Market, By Application Type
41 North America Clinical Oncology Next Generation Sequencing Market, By Workflow Type
42 North America Clinical Oncology Next Generation Sequencing Market, By Country
43 U.S. Clinical Oncology Next Generation Sequencing Market, By Technology Type
44 U.S. Clinical Oncology Next Generation Sequencing Market, By End User
45 U.S. Clinical Oncology Next Generation Sequencing Market, By Application Type
46 U.S. Clinical Oncology Next Generation Sequencing Market, By Workflow Type
47 Canada Clinical Oncology Next Generation Sequencing Market, By Technology Type
48 Canada Clinical Oncology Next Generation Sequencing Market, By End User
49 Canada Clinical Oncology Next Generation Sequencing Market, By Application Type
50 Canada Clinical Oncology Next Generation Sequencing Market, By Workflow Type
51 Mexico Clinical Oncology Next Generation Sequencing Market, By Technology Type
52 Mexico Clinical Oncology Next Generation Sequencing Market, By End User
53 Mexico Clinical Oncology Next Generation Sequencing Market, By Application Type
54 Mexico Clinical Oncology Next Generation Sequencing Market, By Workflow Type
55 Four Quadrant Positioning Matrix
56 Company Market Share Analysis
57 Illumina Inc.: Company Snapshot
58 Illumina Inc.: SWOT Analysis
59 Illumina Inc.: Geographic Presence
60 Thermo Fisher Scientific: Company Snapshot
61 Thermo Fisher Scientific: SWOT Analysis
62 Thermo Fisher Scientific: Geographic Presence
63 F. Hoffmann-La Roche Ltd.: Company Snapshot
64 F. Hoffmann-La Roche Ltd.: SWOT Analysis
65 F. Hoffmann-La Roche Ltd.: Geographic Presence
66 Agilent Technologies: Company Snapshot
67 Agilent Technologies: Swot Analysis
68 Agilent Technologies: Geographic Presence
69 Myriad Genetics: Company Snapshot
70 Myriad Genetics: SWOT Analysis
71 Myriad Genetics: Geographic Presence
72 Perkin Elmer: Company Snapshot
73 Perkin Elmer: SWOT Analysis
74 Perkin Elmer: Geographic Presence
75 Caris Life Sciences: Company Snapshot
76 Caris Life Sciences: SWOT Analysis
77 Caris Life Sciences: Geographic Presence
78 Eurofins Scientific: Company Snapshot
79 Eurofins Scientific: SWOT Analysis
80 Eurofins Scientific: Geographic Presence
81 Qiagen, Inc.: Company Snapshot
82 Qiagen, Inc.: SWOT Analysis
83 Qiagen, Inc.: Geographic Presence
84 Other Companies: Company Snapshot
85 Other Companies: SWOT Analysis
86 Other Companies: Geographic Presence
The Global Clinical Oncology Next Generation Sequencing Market has been studied from the year 2019 till 2028. However, the CAGR provided in the report is from the year 2023 to 2028. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Clinical Oncology Next Generation Sequencing Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
